Researchers call for better linkage of health data during discussions with members of the Bundestag

NFDI4Health and experts from politics, science, and healthcare met in Berlin on 13 March 2024 to discuss the topic of record linkage – the linkage of health data from diverse sources for an individual. The participants consider the meeting a success and are planning further steps: ultimately, the entire population could benefit.

Background Research:

NFDI4Health is part of the National Research Data Infrastructure (NFDI). It aims to make health-related research data available across disciplines and institutions. The major focus of NFDI4Health is record linkage, which involves combining health data from different sources for an individual. This process can better represent an individual’s health status and medical history, potentially aiding in more accurate diagnoses and personalized treatments.

FAQs:

1. What was the purpose of this meeting in Berlin?
Answer: The main agenda for the discussion was ‚record linkage‘ – effectively connecting differing sources of health records for an individual. Participants included experts from politics, science, healthcare sectors as well as members of NFDI4Health.

2. Who are NFDI4Health?
Answer: They are a part of Germany’s National Research Data Infrastructure (NFDI) with their primary focus on making research data related to health more accessible across various domains and institutions.

3. What is record linkage exactly?
Answer: Record linkage refers to combining or connecting various pieces of healthcare information about an individual spread across diverse platforms or sources into a single comprehensive health profile.

4.l How does record linkage benefit individuals?
Answer: By combining comprehensive medical data end-to-end — including appointments, medications prescribed, test results etc — about an individual into one file, it aids in providing personalised treatment plans that cater specifically to his/her needs leading to improved overall care outcomes.

5.What did the participants conclude after their discussion on March 13?
Answer: The participants deemed the meeting as successful and believed it resulted in productive discussions concerning effective linking over vast arrays of personal healthcare records.

6.What is expected after these initial discussions involving members from Bundestag?
Answer: While already considered fruitful,the discussions are only beginning; with further steps being planned toward more efficient utilisation & management concerning fragmentized personal healthcare information.

7. How could the entire population benefit from these developments?
Answer: Advancements in record linkage not only pose implications for healthcare treatment advancements but also for health policy decisions, medical research and public health initiatives which can leverage such detailed data to improve community-wise health outcomes.

Originamitteilung:

NFDI4Health and experts from politics, science, and healthcare met in Berlin on 13 March 2024 to discuss the topic of record linkage – the linkage of health data from diverse sources for an individual. The participants consider the meeting a success and are planning further steps: ultimately, the entire population could benefit.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Gesundheits- und Umweltexperte an der Hochschule Coburg werden

Gesundheit oder Umwelt: Was darfs sein? Wenn Studierende der Hochschule Coburg nach drei Semestern die Grundlagen der Bioanalytik erlernt haben, können sie sich spezialisieren. Auch im Masterstudium dürfen sie ihren Fokus auf Bioinformatik, Ökotoxikologie oder Humanbiologie setzen. Dadurch wird die Lehre flexibler und zeiteffizient. Zwei neuberufene Professoren geben Einblicke in das Studium und ihre Arbeit als Professoren.

Read More

Glioblastom: Humanin blockieren – Chemotherapie wirksam machen

Strahlen- und/oder Chemotherapie nach der Operation – das sind die Behandlungsoptionen bei einem der gefährlichsten Gehirntumore überhaupt, dem Glioblastom. Doch bis heute sind diese Tumoren unheilbar, mit einer mittleren Überlebensdauer von 16 Monaten nach Diagnosestellung. Nun hat ein Team internationaler Forschender unter Federführung von Prof. Dr. Rainer Glaß vom LMU Klinikum München einen Mechanismus entdeckt, der die Krebszellen gegen gängige Chemotherapeutika unempfindlich macht. Die Ergebnisse wurden jetzt in der Fachzeitschrift „Cell Reports Medicine“ veröffentlicht.

Read More